Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a High-Tech suit help people walk again after stroke or spinal injury?

NCT ID NCT07164846

Symptom relief Sponsor: Brooks Rehabilitation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a special suit called the Neuro20 that uses mild electrical pulses to stimulate muscles in the arms, legs, chest, and back. Researchers want to see if wearing it during therapy sessions can improve walking ability, muscle performance, and heart health in people who have had a spinal cord injury, stroke, or amputation. Up to 30 participants will complete 12 sessions, each lasting 1-2 hours, while the team measures changes in how far they can walk and their heart rate variability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neuro20 functional electrical stimulation suit
What this could lead to
If it works, this could offer a new way to help people with nerve injuries walk better and improve their overall health without drugs.
What could go wrong
This is a very small, early-stage study with only 30 participants, so results may not apply to everyone. The suit may cause skin irritation or discomfort from the electrical stimulation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least one week post amputation or neurologic injury (i.e. brain injury, stroke, spinal cord injury) and deemed medically stable to participate in rehabilitation * Able to provide Informed Consent by demonstrating the ability to follow a three step command Exclusion Criteria: * Pacemaker / Defibrillator or severe cardiac disease (Class IV according to New York Heart Association Functional Classification) * Implanted medical devices * Active DVT/thrombophlebitis * Active Cancer * Active fever, infection, or acute inflammation * Pregnancy * Epilepsy or uncontrolled seizures or seizure within the last 6 months * Implanted stimulator or pump that cannot be turned off externally * Significant, active wounds in areas stimulated by the suit * Inability to follow a three-step motor command * Bleeding tendency

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amputees are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

brain injury spinal cord injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amputees Spinal cord injury Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Brooks Rehabilitation

    RECRUITING

    Jacksonville, Florida, 32216, United States

  • The International Institute of Orthotics and Prosthetics

    NOT_YET_RECRUITING

    Tampa, Florida, 33634, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.